期刊文献+

纳米粒载体研究进展 被引量:2

The Research Progress of Nanoparticle Carrier
原文传递
导出
摘要 目的:介绍纳米粒载体的制备、优点和应用进展,为纳米粒在新的领域的应用提供依据。方法:以纳米粒制备方法和基质材料的不断发展以及各个领域的应用为线索来综述。结果:纳米粒的制备方法有离子交换法、乳化法和自组装法,基质材料有蛋白质和多糖等,纳米粒本身无毒性,能增加所载物的溶解度和生物利用度,提高靶向性及效率,在抗肿瘤治疗、神经系统治疗和药物检测等多方面有广泛的应用。结论:纳米粒作为一种载体,在药物临床研究、药理研究和生物分析等方面都得到了广泛应用,并有可能开发为其他领域的运送体系,有广阔的应用前景。 Objective:To recommend the application advances, advantages and preparation methods of Nan particles, so as to provide reference for further research on application in new fields. Methods: The summary was obtained in terms of analysis on the preparation methods, base materials and application. Results.The preparation methods of Nan particles were numerous, the base materials were various and advantages of nanoparticles were obvious. The preparation methods included ion exchange methods, the emulsification methods, the self-assembly methods. Protein and polysaccharides were the most commonly used base materials. Nanoparticle itself was not poisonous, but it can increase the dissolvability of the object that it carried, and enhance bioavailability, targeting property and efficiency. It has been widely used in many areas, such as anti-tumor therapy, nervous system therapy and drug resting. Conclusion: Nan particles as a kind of carrier has been widely used in drug clinical research, pharmacology research, bioassay and so on, showing a wide application prospect.
出处 《现代生物医学进展》 CAS 2009年第7期1373-1376,共4页 Progress in Modern Biomedicine
基金 国家863计划基金支持项目(2007AA10Z349)
关键词 纳米粒载体 制备 应用 研究进展 Nanoparticle carrier Preparation Application Research progress
  • 相关文献

参考文献5

二级参考文献32

  • 1SUN En jie 1, LI Shi pu 2 ,YAN Yu hua 2 CAO Xian ying 2,FENG Ling yun 2 , XIONG Xian li 2,ZHANG Zhu 2 1 College of Materials Science and Engineering 2 Biomedical Materials And Engineering Center Wuhan University of Science and Technol.Selective inhibition of Hepatocarcinoma cells by apatite nanoparticles[J].Chinese Journal of Biomedical Engineering(English Edition),2002,11(2):67-71. 被引量:10
  • 2王建华,温浩,买尔旦.阿苯达唑脂质体的包封率测定及形态观察[J].新疆医学院学报,1994,17(1):18-21. 被引量:9
  • 3张志荣,廖工铁,钱文.均匀设计法优选米托蒽醌毫微球的制备工艺[J].中国医院药学杂志,1994,14(6):246-249. 被引量:14
  • 4Penkler L,Muller RH,Runge SA,et al. Pharmaceutical cyclosporin formulation with improved biopharmaceutical properties, improved physical quality and greater stability, and method for producing said formulation[R]. WHO,1999:56733.
  • 5Bargoni A,Cavalli R,Caputo O,et al. Solid lipid nanoparticles in lymph and plasma after duodenal administration to rats[J]. Pharm Res, 1998;15(5):745.
  • 6Mima CS,Mehnert W,Schafer-Korting M. Solid lipid nanoparticles as drug carries for topical glucocorticoids[J]. Int J Pharm,2000;196(2):165-167.
  • 7Cavalli R,Gasco MR,Chetoni P,et al. Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin [J]. Int J Pharm,2002;238(1-2):241-245.
  • 8Westesen K,Bunjes H,Koch MHJ. Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential[J]. J Control Release,1997;48(2-3):223-236.
  • 9Muhlen A,Schwarz C,Mehnert W. Solid lipid nanoparticles(SLN)for controlled drug delivery-drug release and release mechanism[J]. Eur J Pharm Biopharm, 1998,45(2):149-155.
  • 10Muller RH,Mader K,Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state of the art[J]. Eur J Pharm Biopharm,2000;50(1):161-177.

共引文献55

同被引文献9

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部